The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Symposium

New direction of tumor immunotherapy

Sat. Oct 13, 2018 2:50 PM - 5:00 PM No.6 (Osaka International Convention Center, 10F 1003)

Chairs: Catherine M. Bollard (Cancer and Immunology Research, Children's National Medical Center/George Washington University, USA), Satoshi Takahashi (The Institute of Medical Science, The University of Tokyo, Japan)

【E】

[SY6-1] Adoptive therapy with TCR-gene modified T cells for the treatment of patients with hematological malignancy and solid tumors

Hiroaki Ikeda (Dpt. Oncology, Nagasaki University, Nagasaki, Japan)

Professional Experiences
2016- Professor, Department of Oncology, Nagasaki University Graduate School of Biomedical Sciences
2015- Processor, Department of Immunology-gene Therapy, Mie University Graduate School of Medicine
2009-2015 Associate Professor, Department of Immunology-gene Therapy, Mie University Graduate School of Medicine
2006-2009 Associate Professor, Department of Cancer Vaccine, Mie University Graduate School of Medicine
2004-2006 Associate professor, Institute of Genetic medicine, Hokkaido University
1999-2004 Research Associate, Washington University of St. Louis, MO USA
1996-1999 Medical Stuff, Mie University Hospital
Educations
Nagasaki University, Nagasaki, Japan: Ph.D., 1996, Medical science
Nagasaki University, Nagasaki, Japan: M.D., 1990, Medicine

Abstract password authentication.
Password is written on a program and abstract book.

Password